SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000893838-05-000144
Filing Date
2005-05-23
Accepted
2005-05-23 16:18:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 rex13drexgene.txt SC 13D 14764
2 rextrustagmt.txt EX-2 48627
  Complete submission text file 0000893838-05-000144.txt   65477
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Subject) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-79996 | Film No.: 05851473
SIC: 2834 Pharmaceutical Preparations

Mailing Address 401 WOOYOUNG VENTURE BLDG. SEOCHO-DONG SEOCHO-GU SEOUL M5 1330-13
Business Address 401 WOOYOUNG VENTURE BLDG. SEOCHO-DONG SEOCHO-GU SEOUL M5 1330-13 82-2 587 0019
Rexgene Biotech Co., Ltd. (Filed by) CIK: 0001316425 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M5 | Fiscal Year End: 1231
Type: SC 13D